These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 2519375

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose.
    Abe M, Kaizu K, Matsumoto K.
    Ther Apher Dial; 2007 Aug; 11(4):280-7. PubMed ID: 17661834
    [Abstract] [Full Text] [Related]

  • 5. Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients.
    Ersoy FF, Karayalcin U, Karayalcin B, Sapan M, Bozcuk H, Süleymanlar G, Yakupoglu G.
    Adv Perit Dial; 1995 Aug; 11():119-22. PubMed ID: 8534683
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hemodialysis-induced hypoglycemia in diabetic patients.
    Jackson MA, Holland MR, Nicholas J, Lodwick R, Forster D, Macdonald IA.
    Clin Nephrol; 2000 Jul; 54(1):30-4. PubMed ID: 10939754
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
    Rottembourg J, Balducci A, Baumelou A, Jacq D, Agrafiotis A, Slama G.
    Proc Clin Dial Transplant Forum; 1980 Jul; 10():305-7. PubMed ID: 7050993
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of chronic renal insufficiency in the diabetic by dialysis and transplantation].
    Legrain M, Rottembourg J, Jacobs C.
    Diabete Metab; 1985 Feb; 11(1):51-69. PubMed ID: 3884405
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Advantages of insulin Lispro (short-acting) in terminal kidney failure].
    Jehle PM, Aisenpreis U, Bundschu D, Keller F.
    Fortschr Med; 1999 Apr 20; 117(11):41-2. PubMed ID: 10339922
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The behavior of blood insulin and glucose in diabetic nephropathy under CAPD].
    Thomae U, Kuhlmann H, Boos W, Herrmann M, Eberhard K.
    Med Welt; 1980 Oct 31; 31(44):1599-601. PubMed ID: 7005589
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.